Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label chloral hydrate trial in adults with severe insomnia
ISRCTN10433315Phase 4Completed
- Sponsor
- Atnahs
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of chloral hydrate in Insomnia, sponsored by Atnahs. Primary endpoint: Change in self-rated insomnia severity at 2 weeks. Started Sep 2023; status: completed.
02
Drugs
chloral hydrate
03
Conditions
Insomnia
Beyond the preview
Go deeper on ISRCTN10433315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10433315.